Galantamine hydrobromide and Agitation - a phase IV clinical study of FDA data

Summary:

Agitation is reported as a side effect among people who take Galantamine hydrobromide (galantamine hydrobromide), especially for people who are male, 60+ old, have been taking the drug for < 1 month also take Aspirin, and have Dementia alzheimer's type.

The phase IV clinical study analyzes which people have Agitation when taking Galantamine hydrobromide. It is created by eHealthMe based on reports of 2,357 people who have side effects when taking Galantamine hydrobromide from the FDA, and is updated regularly.

What is Galantamine hydrobromide?

Galantamine hydrobromide has active ingredients of galantamine hydrobromide. It is often used in dementia. eHealthMe is studying from 2,418 Galantamine hydrobromide users. Check the latest studies of Galantamine hydrobromide.

What is Agitation?

Agitation (state of anxiety or nervous excitement) is found to be associated with 2,281 drugs and 3,318 conditions by eHealthMe. Check the latest studies of Agitation.

eHealthMe: drug outcomes in the real world

eHealthMe runs one of the largest post-marketing drug safety studies in the world. We study millions of patients and 5,000 more each day. Our data-driven phase IV clinical trials have been referenced on 800+ peer-reviewed medical publications including The Lancet, Mayo Clinic Proceedings, and Nature. Tools to study our phase IV findings are available to the public, anonymous and free >>>.



On Sep, 01, 2026

2,357 people reported to have side effects when taking Galantamine hydrobromide.
Among them, 78 people (3.31%) have Agitation.

Could Galantamine hydrobromide cause Agitation?

Among these 78 people:

How long have people been on Galantamine hydrobromide when they have Agitation? *

  • < 1 month: 68.75 %
  • 1 - 6 months: 25.0 %
  • 6 - 12 months: 6.25 %
  • 1 - 2 years: 0.0 %
  • 2 - 5 years: 0.0 %
  • 5 - 10 years: 0.0 %
  • 10+ years: 0.0 %

What is the gender of people who have Agitation when taking Galantamine hydrobromide? *

  • female: 44.87 %
  • male: 55.13 %

What is the age of people who have Agitation when taking Galantamine hydrobromide? *

  • 0-1: 0.0 %
  • 2-9: 0.0 %
  • 10-19: 1.47 %
  • 20-29: 1.47 %
  • 30-39: 0.0 %
  • 40-49: 1.47 %
  • 50-59: 2.94 %
  • 60+: 92.65 %

What are other drugs people take besides Galantamine hydrobromide? *

  1. Aspirin: 14 people, 17.95%
  2. Seroquel: 8 people, 10.26%
  3. Risperdal: 7 people, 8.97%
  4. Hydrochlorothiazide: 5 people, 6.41%
  5. Simvastatin: 5 people, 6.41%
  6. Prilosec: 5 people, 6.41%
  7. Depakote: 5 people, 6.41%
  8. Namenda: 5 people, 6.41%
  9. Sertraline: 5 people, 6.41%
  10. Lipitor: 4 people, 5.13%

What are other side effects people have besides Agitation? *

  1. Confusional State: 23 people, 29.49%
  2. Aggression: 15 people, 19.23%
  3. Abnormal Behavior: 13 people, 16.67%
  4. Insomnia (sleeplessness): 13 people, 16.67%
  5. Hallucinations (sensations that appear real but are created by your mind): 11 people, 14.10%
  6. Fall: 10 people, 12.82%
  7. Death: 9 people, 11.54%
  8. Drowsiness: 9 people, 11.54%
  9. Unresponsive To Stimuli: 8 people, 10.26%
  10. Appetite - Decreased (decreased appetite occurs when you have a reduced desire to eat): 8 people, 10.26%

What are the existing conditions these people have? *

  1. Dementia Alzheimer's Type (loss of mental ability with alzheimer's symptom): 23 people, 29.49%
  2. High Blood Pressure: 6 people, 7.69%
  3. Parkinson's Disease: 6 people, 7.69%
  4. Stress And Anxiety: 3 people, 3.85%
  5. Depression: 3 people, 3.85%
  6. Hyperlipidaemia (presence of excess lipids in the blood): 3 people, 3.85%
  7. Hallucinations (sensations that appear real but are created by your mind): 2 people, 2.56%
  8. Indigestion: 2 people, 2.56%
  9. Folate Deficiency (lack of folic acid): 2 people, 2.56%
  10. Gastroesophageal Reflux Disease (a condition in which stomach contents leak backward from the stomach into the oesophagus): 2 people, 2.56%

* Approximation only. Some reports may have incomplete information.

Do you take Galantamine hydrobromide and have Agitation?

- Check whether Agitation is associated with a drug or a condition
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously



Related studies:

Effectiveness of, long term effects of, and alternative drugs to Galantamine hydrobromide:

Agitation treatments and more:

How severe was Agitation and when was it recovered:

Expand to all the drugs that have ingredients of galantamine hydrobromide:

Sub-studies by gender and age:

Female: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Male: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Browse all side effects of Galantamine hydrobromide:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all the drugs that are associated with Agitation:

Browse all the conditions that are associated with Agitation:

Related publications that referenced our studies


How the study uses the data?

The study uses data from the FDA. It is based on galantamine hydrobromide (the active ingredients of Galantamine hydrobromide) and Galantamine hydrobromide (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.



Recent studies on eHealthMe: